Indivior Pharmaceuticals Inc
Health
Performance
3.8
Risk
Sell
Buy
Curious about the Scores? Learn more.

Indivior Pharmaceuticals Inc stock rating and score history

All changes in ratings, performance and outlook tracked over time.

05.06.2026
Calmer waters ahead. Risk signals cooling off.
04.06.2026
From weak to decent. The first signs are finally showing.
21.04.2026
Outperforming hard. Momentum locked in.
20.08.2025
Climbing out. Risks fading, but not out of the woods.
INDV
Indivior Pharmaceuticals Inc
37.45
+5.70%
3.8
Sell
Buy
Indivior Pharmaceuticals Inc

Indivior Pharmaceuticals Inc stock price, chart patterns and momentum

Recent price movements, trend behaviour and momentum signals based on real-time market data.

What does Indivior Pharmaceuticals Inc do? Business model and key facts

Get the full picture of Indivior Pharmaceuticals Inc: what it builds, where it operates, and how it makes money.

Indivior Pharmaceuticals Inc Profile

Sector: Healthcare

Industry: Drug Manufacturers - Specialty & Generic

Employees (FY): 1030

Indivior Pharmaceuticals Inc is a holding company, which engages in the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence. Its products include Suboxone Film, Suboxone Tablet, and Subutex Tablet. It operates through the following geographical segments: United States, Rest of World, and United Kingdom. The company was founded on September 26, 2014 and is headquartered in North Chesterfield, VA.

shop
Company facts
Joseph J. Ciaffoni
CEO
1030
Employees worldwide
shop
Performance
173.96%
Last 12 months
234.38%
Last 5 years
shop
Growth
$1,19B
Revenue year
$2,00M
Net income
shop
Valuation
$4,49B
Market Cap
820.38
Price/Earnings Ratio

Stocks related to Indivior Pharmaceuticals Inc

Selected based on industry alignment and relative market positioning.

LNTH
Lantheus Holdings, Inc.
102.82
+2.56%
5.0
Sell
Buy
Lantheus Holdings, Inc.
RDY
Dr. Reddy's Laboratories Limited
13.24
+1.65%
2.4
Sell
Buy
Dr. Reddy's Laboratories Limited
ELAN
Elanco Animal Health Incorporated
24.71
+0.57%
5.1
Sell
Buy
Elanco Animal Health Incorporated
AMRX
Amneal Pharmaceuticals, Inc.
13.52
+5.01%
4.1
Sell
Buy
Amneal Pharmaceuticals, Inc.
SUPN
Supernus Pharmaceuticals, Inc.
44.70
+1.51%
4.3
Sell
Buy
Supernus Pharmaceuticals, Inc.

Events and news impacting Indivior Pharmaceuticals Inc stock

Earnings, coporate decisions and industry developments that can affect the share price.

Indivior Pharmaceuticals Inc fundamentals and technical analysis

Financial fundamentals and technicals signals combined to access stability, momentum and market direction.